Developed to help people with type 2 diabetes control their blood sugar levels, these GLP-1 medications have generated billions of dollars in revenue for their ability to slow the pace of digestion and reduce appetite, helping millions worldwide lose weight
To make a correlation that GLP-1s cause NAION would be a big leap, she said
The Science of the GLP-1 "Super Responders" In the rapidly evolving landscape of weight loss medications, a new term has moved from clinical journals to viral social media: the "Super Responder." While medications like Wegovy and Zepbound are effective for the majority of users, a specific subset of patients experiences weight loss that far exceeds clinical averages
For Novo Nordisk, this century-old grudge match was also personal
One clinical observation: patients mixing high-fiber foods with semaglutide's appetite suppression sometimes under-eat fiber by accidenttrack your intake using a food app to ensure you hit 3035 grams daily
Finally, he will remove any excess skin if needed and then suture the incisions